NO823426L - Soetningstablett. - Google Patents
Soetningstablett.Info
- Publication number
- NO823426L NO823426L NO823426A NO823426A NO823426L NO 823426 L NO823426 L NO 823426L NO 823426 A NO823426 A NO 823426A NO 823426 A NO823426 A NO 823426A NO 823426 L NO823426 L NO 823426L
- Authority
- NO
- Norway
- Prior art keywords
- apm
- tablet
- solubility
- parts
- sweetening
- Prior art date
Links
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 23
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 14
- 239000000945 filler Substances 0.000 claims description 14
- 239000004471 Glycine Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 229920000881 Modified starch Polymers 0.000 claims description 4
- 239000004368 Modified starch Substances 0.000 claims description 4
- 235000019426 modified starch Nutrition 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000008137 solubility enhancer Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- FETSQPAGYOVAQU-UHFFFAOYSA-N glyceryl palmitostearate Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O FETSQPAGYOVAQU-UHFFFAOYSA-N 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-N methyl hydrogen carbonate Chemical compound COC(O)=O CXHHBNMLPJOKQD-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
- A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Seasonings (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP82108001A EP0101755A1 (de) | 1982-08-31 | 1982-08-31 | Wassarlösliche, durch Pressen verfestigte Süssungstablette |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO823426L true NO823426L (no) | 1984-03-01 |
Family
ID=8189199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO823426A NO823426L (no) | 1982-08-31 | 1982-10-14 | Soetningstablett. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4486455A (es) |
| EP (1) | EP0101755A1 (es) |
| JP (1) | JPS5945850A (es) |
| AU (1) | AU546972B2 (es) |
| DK (1) | DK459482A (es) |
| ES (1) | ES8403707A1 (es) |
| FI (1) | FI823241L (es) |
| NO (1) | NO823426L (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0631312B2 (ja) * | 1983-03-18 | 1994-04-27 | 味の素株式会社 | ジペプチド結晶及びその製造方法 |
| JPS60241871A (ja) * | 1984-05-16 | 1985-11-30 | Ajinomoto Co Inc | アスパルテ−ム含有崩壊錠剤の製造法 |
| US5069924A (en) * | 1989-04-21 | 1991-12-03 | The Southland Corporation | Low calorie beverage |
| US4986994A (en) * | 1989-04-21 | 1991-01-22 | The Southland Corporation | Process for making a low calorie beverage |
| US5139797A (en) * | 1990-04-27 | 1992-08-18 | Leaf, Inc. | Stabilized sweetener compositions, chewing gum compositions containing same and methods for their preparation |
| EP0583470A4 (en) * | 1992-01-10 | 1995-07-26 | Obschestvo S Ogranichennoy Otv | PHARMACEUTICAL COMPOSITION IN GRANULATE FORM AND PRODUCTION METHOD. |
| US5587178A (en) * | 1992-06-11 | 1996-12-24 | Holland Sweetner Company V.O.F. | Process for the treatment of aspartame |
| NL9201029A (nl) * | 1992-06-11 | 1994-01-03 | Holland Sweetener Co | Werkwijze voor het bewerken van aspartaam. |
| CN1110112A (zh) * | 1994-04-11 | 1995-10-18 | 贾增申 | 一种氨基酸固体饮料及其制备方法 |
| WO1995027408A1 (en) * | 1994-04-11 | 1995-10-19 | East Wellsum Industries(S) Pte. Ltd. | Sweetening agent containing glycine, l-proline and/or l-hydroxyproline |
| FR2745981B1 (fr) * | 1996-03-15 | 1998-06-05 | Agent adsorbant diminuant ou eliminant les effets secondaires lies a l'absorption d'agents edulcorants | |
| DE10211427A1 (de) * | 2002-03-15 | 2003-10-02 | Rettenmaier & Soehne Gmbh & Co | Zur alsbaldigen Auflösung in Flüssigkeit bestimmter Preßling |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1091144A (en) * | 1964-03-05 | 1967-11-15 | Monsanto Co | Synthetic sweetening compositions |
| US4009291A (en) * | 1974-03-25 | 1977-02-22 | General Foods Corporation | Cold water soluble stable bulked starch |
| US4031259A (en) * | 1975-08-13 | 1977-06-21 | General Foods Corporation | Process of preparing nutritive sweetening compositions |
| CH627926A5 (en) * | 1976-01-22 | 1982-02-15 | Gen Foods Corp | Sweetening agent, process for the preparation thereof and use thereof |
| US4230687A (en) * | 1978-05-30 | 1980-10-28 | Griffith Laboratories U.S.A., Inc. | Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices |
| EP0014554A1 (en) * | 1979-02-06 | 1980-08-20 | TATE & LYLE PATENT HOLDINGS LIMITED | Sweetening compositions containing peptide sweeteners and a method for their manufacture |
| US4384004A (en) * | 1981-06-02 | 1983-05-17 | Warner-Lambert Company | Encapsulated APM and method of preparation |
| US4703785A (en) * | 1986-04-18 | 1987-11-03 | Thetford Corporation | Tank fill assist |
-
1982
- 1982-08-31 EP EP82108001A patent/EP0101755A1/de not_active Ceased
- 1982-09-21 FI FI823241A patent/FI823241L/fi not_active Application Discontinuation
- 1982-09-30 AU AU88909/82A patent/AU546972B2/en not_active Ceased
- 1982-09-30 US US06/431,071 patent/US4486455A/en not_active Expired - Fee Related
- 1982-10-08 ES ES516370A patent/ES8403707A1/es not_active Expired
- 1982-10-14 NO NO823426A patent/NO823426L/no unknown
- 1982-10-15 DK DK459482A patent/DK459482A/da not_active Application Discontinuation
- 1982-10-15 JP JP57180109A patent/JPS5945850A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES516370A0 (es) | 1984-04-01 |
| US4486455A (en) | 1984-12-04 |
| FI823241A0 (fi) | 1982-09-21 |
| JPS6350988B2 (es) | 1988-10-12 |
| DK459482A (da) | 1984-03-01 |
| ES8403707A1 (es) | 1984-04-01 |
| FI823241L (fi) | 1984-03-01 |
| EP0101755A1 (de) | 1984-03-07 |
| AU8890982A (en) | 1984-03-08 |
| AU546972B2 (en) | 1985-09-26 |
| JPS5945850A (ja) | 1984-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO823426L (no) | Soetningstablett. | |
| Yamori et al. | Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats. | |
| Williams et al. | Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats | |
| Evans et al. | Zinc absorption in rats fed a low-protein diet and a low-protein diet supplemented with tryptophan or picolinic acid | |
| Wagner et al. | Effect of vitamins C and E on endogenous synthesis of N-nitrosamino acids in humans: precursor-product studies with [15N] nitrate | |
| Spolter et al. | Leucine-isoleucine antagonism in the rat | |
| US2824008A (en) | Salt substitute | |
| JP2003514776A (ja) | 代謝性骨疾患治療用薬剤組成物及びその製造方法 | |
| CA2047453A1 (en) | Low moisture cholestyramine composition | |
| Dall et al. | Changes in protein-bound and free amino acids in the muscle of the tiger prawn Penaeus esculentus during starvation | |
| NO823427L (no) | Soetningstablett. | |
| US5562919A (en) | Dried animal plasma as a pharmaceutical excipient for compressed tablet formulation | |
| JP5833545B2 (ja) | 男性不妊の治療のための、ｄ−アスパラギン酸とｌ−アスパラギン酸またはこれら酸の塩の組み合わせの使用 | |
| JPH08253418A (ja) | 高血圧症の治療、抗高血圧及び利尿のためのチアジド化合物及び組成物 | |
| US4067974A (en) | Stabilized solid form choline salicylate compositions | |
| JPH0115269B2 (es) | ||
| Maniar et al. | In vivo unaltered muscle protein synthesis in experimental chronic metabolic acidosis | |
| Schneeman et al. | Nutritional and gastrointestinal response to heated nonfat dry milk | |
| JP3248170B2 (ja) | コンドロイチン硫酸蛋白複合体含有食品 | |
| CA2403674C (en) | The use of t3 for treating congestive heart failure | |
| Olesen et al. | A preventive effect of potassium against fatal lithium intoxication in rats | |
| Benigni et al. | Preliminary report: renal thromboxane A2 synthesis in children with frequent relapsing nephrotic syndrome | |
| Alexander et al. | The influence of lipotropic factors on the prevention of nutritional edema in the rat | |
| de Keijzer et al. | Enhanced urinary excretion of eicosanoids in fawn-hooded rats | |
| JPH111431A (ja) | 肥満抑制剤 |